ArticleActa neurologica Belgica2026
Pain in neuromyelitis optica spectrum disorder: determination of prevalence and characteristics.
Article in Acta neurologica Belgica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe aim was to determine the prevalence and characteristics of pain in people with neuromyelitis optica spectrum disorders (pwNMOSD).
methodsThe Nordic Musculoskeletal Questionnaire (NMQ) was used to determine the participants' pain levels and pain localization. The PainDETECT Questionnaire (PD-Q) was used to differentiate between nociceptive and neuropathic pain. The scores ≤ 12 were considered as presence of musculoskeletal pain (MSP) and > 12 as neuropathic pain (NP). The Preference-Based Multiple Sclerosis Index (PBMSI) was used to measure health-related quality of life. Information such as Expanded Disability Status Scale (EDSS), disease duration and age of the participants were also recorded.
resultsThe 62 participants included in the study were divided into 3 groups: 14 without pain, 17 with MSP and 31 with NP. There was no difference between the groups in terms of age, disease duration and EDSS scores (p > .05). When the pain distribution was analyzed, the regions with the most pain complaints in the last 12 months were neck (n = 22, 34.9%), foot-ankle (n = 16, 25.4%) and back (n = 15, 25.8%), respectively. When the quality of life of the three groups were compared, there was a difference between PBMSI-Walk, PBMSI-Fatigue and total score.
conclusionThe results of this study showed that the neck, back, and foot-ankle were the most common and most disabling pain areas in pwNMOSD, regardless of the age, disease duration, and EDSS score of the participant. However, there was a difference between the groups in the parameters related to gait, fatigue and total quality of life against NP.
Indexed as
Identifiers
41307841What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.